| Literature DB >> 32438614 |
Anthony Estienne1,2,3,4, Adeline Brossaud1,2,3,4, Maxime Reverchon5, Christelle Ramé1,2,3,4, Pascal Froment1,2,3,4, Joëlle Dupont1,2,3,4.
Abstract
Some evidence shows that body mass index in humans and extreme weights in animal models, including avian species, are associated with low in vitro fertilization, bad oocyte quality, and embryo development failures. Adipokines are hormones mainly produced and released by white adipose tissue. They play a key role in the regulation of energy metabolism. However, they are also involved in many other physiological processes including reproductive functions. Indeed, leptin and adiponectin, the most studied adipokines, but also novel adipokines including visfatin and chemerin, are expressed within the reproductive tract and modulate female fertility. Much of the literature has focused on the physiological and pathological roles of these adipokines in ovary, placenta, and uterine functions. The purpose of this review is to summarize the current knowledge regarding the involvement of leptin, adiponectin, visfatin, and chemerin in the oocyte maturation, fertilization, and embryo development in both mammals and birds.Entities:
Keywords: adipokines; birds; early embryo development; mammals; oocyte maturation
Mesh:
Substances:
Year: 2020 PMID: 32438614 PMCID: PMC7279299 DOI: 10.3390/ijms21103581
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1(A) Oocyte maturation and fertilization in mammals. (B) Description of the different steps of oocyte development from fetal life, birth, ovulation to fertilization.
Figure 2Different steps of the early embryo development in mammals.
Figure 3Different steps of the folliculogenesis in birds.
Figure 4Structure of an avian oviduct with reference to sperm storage sites.
Figure 5Some steps of early embryo development (intrauterine) in chicken.
Gene location, protein expression, and synthesis of adipokines and its receptors in mammals (humans).
| Protein (Name) | Gene | Gene Location | Protein (Description) | Synthesis | References |
|---|---|---|---|---|---|
| Leptin |
| 7q32.1 | 167 aa | WAT but also placenta | [ |
| Leptin Receptor |
| 1p31.3. | 1.165 aa (6 isoforms, a to f). LepR-b has intracellular signaling. LepR-e is a soluble receptor and binds plasma leptin. | LepR-b: strongly expressed in hypothalamus, but also in skeletal muscle. Ubiquitous | [ |
| Adiponectin |
| 3q27.3. | 244 aa | Adipocytes | [ |
| ADIPOR1 |
| 1q32.1 | 375 aa | Skeletal muscles and ubiquitously | [ |
| ADIPOR2 |
| 12p13.33 | 386 aa | Liver and ubiquitously | [ |
| Visfatin |
| 7q22.3 | 491 aa | ubiquitously | [ |
| Chemerin |
| 7q36.1 | 163 aa | White adipose tissue and liver | [ |
| CMKLR1 |
| 12q23.3 | 373 aa | ubiquitously | [ |
| GPR1 |
| 2q33.3 | 355 aa | ubiquitously | [ |
| CCRL2 |
| 3p21.31 | 344 aa | ubiquitously | [ |
Figure 6Leptin, adiponectin, visfatin, and chemerin and their receptors.
Gene location, protein expression, and synthesis of adipokines and its receptors in birds (chicken).
| Protein (Name) | Gene | Gene Location | Protein (Description) | Synthesis | References |
|---|---|---|---|---|---|
|
| LEP | Chr 1 (1p) | 198 aa | mainly in brain and pituitary | [ |
|
| LEPR | Chr8 | 1146 aa | ubiquitously | [ |
|
| ADIPOQ | Chr9 | 244 aa | mainly fat tissue, heart, stomach and skin and ubiquitously | [ |
|
| ADIPOR1 | Chr32 | 376 aa | ubiquitously | [ |
|
| ADIPOR2 | Chr1 | 387 aa | ubiquitously | [ |
|
| NAMPT | Chr1 | 493 aa | ubiquitously | [ |
|
| RARRES2 | Chr2 | 162 aa | mainly liver (turkey) | [ |
|
| CMKLR1 | Chr15 | 360 aa | ubiquitously | [ |
|
| GPR1 | Chr7 | 420 aa | ubiquitously | [ |
|
| CCRL2 | Nd | nd | Pectoralis muscle and ubiquitously | [ |
Chr: chromosome, aa: amino acids.
Amino acid sequence identity between chicken and human species.
| Protein | Leptin | Leptin Receptor | Adiponectin | ADIPOR1 | ADIPOR2 | Visfatin | Chemerin | CMKLR1 | GPR1 | CCRL2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Identity % | 30 | 47 | 57 | 91 | 82 | 94 | 36 | 56 | 64 | nd |
| Accession number or ref. | [ | P48357 and | [ | [ | [ | [ | Q99969 and | Q99788 and | F1NYB0 and |
nd: undetermined.
The consequences on the female fertility of targeted or total disruption or overexpression of components of some adipokine signaling pathways.
| Adipokine Component Modified | Genetic Transformation | Ovarian Consequences | References |
|---|---|---|---|
|
| Total Knockout (KO) | no mature follicles or corpora lutea were detected | [ |
|
| -Total KO (db mice) | -Reduction of ovarian functions that are not due to Leptin-R expression in ovary | [ |
|
| -Total KO | -Reduction of oocytes retrieval, disruption of estrous cycle, elevation of atretic follicles number, and decrease in late folliculogenesis | [ |
Examples of adipokines and adipokine receptors expression in oocyte and embryos in several species.
| Protein | Oocytes | Embryos |
|---|---|---|
| Leptin | Mice (protein, [ | Mouse and Human [ |
| Leptin receptor | Rodent (protein, [ | Chicken [ |
| Adiponectin | Rat [ | Rabbit [ |
| Adiponectin Receptors | Rat [ | Rabbit [ |
| Visfatin | Rodent [ | Chicken [ |
| Chemerin | Bovine [ | Chicken [ |
| Chemerin receptors | Bovine [ | Chicken [ |
Figure 7Effects of leptin on in vivo or in vitro oocyte maturation (IVM), in vitro fertilization, and in vivo or in vitro embryo development in different species. ICSI: Intracytoplasmic Spermatozoon Injection FF: Follicular Fluid. ART: Assisted Reproductive Technology.
Description of experiments (cell type, species, time of incubation, dose and origin of leptin, etc.,) investigating the effect of leptin treatment on in vitro oocyte maturation and/or embryo development.
| Cell Type | Species | Time of Incubation | Dose ng/mL | Origin of Leptin | Medium | Effects on Oocyte and/or Embryo | References |
|---|---|---|---|---|---|---|---|
| -Secondary follicle | sheep | 18 days | 25 | human | α-MEM+ | [ | |
| COCs | buffalo | 24 h (IVM), 48 h (cleavage rate) and day 8 post IVF (blastocyst rate) | 10 | nd | TCM-199 (IVM) | [ | |
| COCs | buffalo | 24 h (IVM) | 10 and 50 | mouse | TCM-199 | [ | |
| Preantral follicles and COCs | sheep | 6 days and 24 h for IVM | 10 | human | TCM-199 | [ | |
| COCs | buffalo | 24 h (IVM) | 10 | mouse | TCM-199 | [ | |
| COCs | calf | 24 h (IVM) | 1 or 10 | nd | TCM-199 | [ | |
| COCs | Prepubertal calf | 24 h (IVM) | 10, 100 or 1000 | human | TCM-199 (IVM)FerTALP (IVC) | No effect on cleavage and blastocyst levels | [ |
| COCs | bovine | 24 h (IVM) | 10, 100 | human | TCM-199 FerTALP (IVC) | [ | |
| COCs | rabbit | 16 h (IVM) | 1, 10, 100 | nd | TCM-199 | [ | |
| COCs | horse | 28 to 30 h (IVM) | 100 | human | TCM-199 | [ | |
| COCs | mouse | 24 h (IVM) | 10 | mouse | M16 | [ | |
| COCs | bovine | 20–22 h (IVM) | 1, 10 | human | TCM-199 | [ | |
| COCs | bovine | 22–24 h (IVM) | 1, 10, 100 | human | TCM-199FerTALP (IVC) | [ | |
| COCs | pig | 24–48 h (IVM) | 10, 100, 1000 | human | TCM-199 | [ | |
| Preovulatory follicle-enclosed oocytes | mouse | 24 h (IVM) | 10, 100, 1000 | human | TCM-199 | [ |
Notes: FerTALP: Tyrode-albumin-lactate-pyruvate fertilization media; IVC: in vitro embryo Culture, MII: metaphase II, GVBD: Germinal Vesicle Breakdown; IVM: in vitro maturation; COCs: Cumulus-Oocyte-Complexes; IVF: In Vitro Fertilization. : increase; : decrease.
Figure 8Effects of adiponectin on in vitro oocyte maturation, fertilization, and embryo development in different species. GC: Granulosa cells; P4: Progesterone; E2: Estradiol; PCOS: Polycystic Ovary Syndrome.
Figure 9Effects of visfatin (in blue) and chemerin (in red) on in vivo and in vitro oocyte maturation, fertilization, and embryo development in different species. GC: Granulosa cells; IGF1: Insulin Growth Factor 1; FF: Follicular Fluid; ART: Assisted Reproductive Technology.
Figure 10Expression of adipokines and their receptors in the ovarian follicle and embryo.